Re:Why you should, and shouldn’t, join a startup
by slededit on Tuesday August 14, 2018 @05:58PM
(#17762293)
An incumbent's return will be weighed down by lost share from their legacy business. Colloquially known as the innovators dilemma.
Even if they overcome it they will still have lower returns than a startup who steals 100% of their market share from incumbents.
Biopharma is a perfect example. It represents over 20% of venture funding. Most entrepreneurs are 50+ years old. Big companies get orders of magnitude lower return on r&d investment than VC backed companies. And the returns have actually been better than tech startups in the last few years